Skip to main content

Advertisement

Springer Nature Link
Log in

Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells

  • Research Article
  • Published:
Tumor Biology

Abstract

Sirtuins belong to the family of class III histone deacetylases; its role in neoplasia is controversial as both tumor-suppressive and promoting functions have been reported. There are very few reports available, where expressions of sirtuin isoforms are comprehensively analyzed during neoplasia. Therefore, in the present study, the expression of SIRT1, SIRT2, and SIRT7 during different stages of cervical cancer progression was analyzed. The normal cervical epithelium showed feeble expression of sirtuin isoforms, SIRT1, SIRT2, and SIRT7. A significant increase in SIRT1 expression was noted in the cytoplasm as well as in the nucleus of proliferative layers of cervical epithelium in squamous intraepithelial lesions (SIL); however, in the squamous cell carcinomas (SCC), a heterogeneous pattern of SIRT1 expression varying from low to high was noted. A progressive increase in the expression of both SIRT2 and SIRT7 was noted during cancer progression in the following order: normal < preneoplasia < cancer. Cervical cancer cell lines, HeLa and SiHa, showed higher levels of SIRT1 and SIRT2 in comparison to the immortalized cell counterpart, HaCaT. Specific inhibitors of SIRT1 (Ex527) and SIRT2 (AGK2) impaired the growth of the cervical cancer cells, SiHa, but not of the HaCaT cells. SIRT1 inhibition caused cell death, while SIRT2 inhibition resulted in cell cycle arrest. In conclusion, we report the overexpression of SIRT2 and SIRT7 proteins in cervical cancer and suggest probable application of sirtuin inhibitors as therapeutic targets. Further, a specific increase in the levels of SIRT1 in intraepithelial lesion makes it a promising candidate for identification of preneoplastic changes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

SIRT:

Sirtuin

IHC:

Immunohistochemistry

SIL:

Squamous intraepithelial lesion

SCC:

Squamous cell carcinoma

References

  1. Haigis MC, Sinclair DA. Mammalian sirtuins: biological insights and disease relevance annual review of pathology: mechanisms of disease. Annu Rev Pathol Mech Dis. 2010;5:253–95.

    Article  CAS  Google Scholar 

  2. Nogueiras R, Habegger KM, Chaudhary N, Finan B, Banks AS, Dietrich MO, et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev. 2012;92:1479–14.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Polito L, Kehoe PG, Forloni G, Albani D. The molecular genetics of sirtuins: association with human longevity and age-related diseases. Int J Mol Epidemiol Genet. 2010;1:214–25.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Presegue LB, Vaquero A. Dual role of sirtuins in cancer. Gene Cancer. 2011;2:648–62.

    Article  Google Scholar 

  5. Deng CX. SIRT1, is it a tumor promoter or tumor suppressor? Int J Biol Sci. 2009;5:147–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, et al. hSIR2 (SIRT1) functions as an NAD-dependent p53 deacetylase. Cell. 2001;107:149–59.

    Article  CAS  PubMed  Google Scholar 

  7. Li S, Banck M, Mujtaba S, Zhou MM, Sugrue MM, Walsh MJ. p53-induced growth arrest is regulated by the mitochondrial SirT3 deacetylase. PLoS One. 2010;5:e10486.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wang R, Sengupta K, Li C, Kim H, Cao L, Xiao C, et al. Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. 2008;14:312–23.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Kim HS, Patel K, Jacobs KM, Bisht KS, Aykin-Burns N, Pennington JD, et al. SIRT3 is a mitochondrial-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress. Cancer Cell. 2010;17:41–52.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. North BJ, Verdin E. Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation. J Biol Chem. 2007;282:19546–55.

    Article  CAS  PubMed  Google Scholar 

  11. Jeong SM, Xiao C, Finley LWS, Lahusen T, Souza AL, Pierce K, et al. SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism. Cancer Cell. 2013;23:450–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Van Meter M, Mao Z, Gorbunova V, Seluanov A. Repairing split ends: SIRT6, mono-ADP ribosylation and DNA repair. Aging. 2011;3:829–35.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Barber MF, Michishita-Kioi E, Xi Y, Tasselli L, Kioi M, Mogtaderi Z, et al. SIRT7 link H3K18 deacetylation to maintenance of oncogenic transformation. Nature. 2012;487:114–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Cha EJ, Noh SJ, Kwon KS, Kim CY, Park BH, Park HS, et al. Expression of DBC1 and SIRT1 is associated with poor prognosis of gastric carcinoma. Ciln Cancer Res. 2009;15:4453–9.

    Article  CAS  Google Scholar 

  15. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998;58:5489–94.

    CAS  PubMed  Google Scholar 

  16. Huffman DM, Grizzle WE, Bamman MM, Kim JS, Eltoum IA, Elgavish A, et al. SIRT1 is significantly elevated in mouse and human prostate cancer. Cancer Res. 2007;67:6612–8.

    Article  CAS  PubMed  Google Scholar 

  17. Chen J, Zhang B, Wong N, Lo AWI, To KF, Chang AWH, et al. Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. Cancer Res. 2011;71:4138–49.

    Article  CAS  PubMed  Google Scholar 

  18. Kim JK, Noh JH, Jung KH, Eun JW, Bae HJ, Kim MG, et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology. 2013;57:1055–67.

    Article  CAS  PubMed  Google Scholar 

  19. Kim HS, Vassilopoulous A, Wang RH, Lahusen T, Xiao T, Xu X, et al. SIRT2 maintain genomic integrity and suppresses tumorigenesis through regulating APC/C activity. Cancer Cell. 2011;20:487–99.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. McGlynn LM, Zino S, MacDonald AI, Curle J, Reilly JE, Mohammed ZM, et al. SIRT2: tumor suppressor or tumor promoter in operable breast cancer. Eur J Cancer. 2014;50:290–301.

    Article  CAS  PubMed  Google Scholar 

  21. Finley LW, Carracedo A, Lee J, Souza A, Egia A, Zhang J, et al. SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell. 2011;19:416–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Alhazzazi TY, Kamarajan P, Joo N, Huang JY, Verdin E, D’Silva NJ, et al. Sirtuin-3(SIRT3), a novel potential therapeutic target for oral cancer. Cancer. 2011;117:1670–8.

    Article  CAS  PubMed  Google Scholar 

  23. Marquardt JU, Fischer K, Teufel A, Krupp M, Thorgeirsson SS, Galle PR, et al. Loss of SIRT6 in hepatocellular carcinoma: associated molecular traits and clinical implications. Z Gastroenterol. 2012;50:5–34.

    Google Scholar 

  24. Benavente CA, Schnell SA, Jacobson EL. Effects of niacin restriction on sirtuin and PARP responses to photodamage in human skin. PLoS One. 2012;7:e42276.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Lai CC, Lin PM, Lin SF, Hsu CH, Lin HC, Hu ML, et al. Altered expression of SIRT gene family in head and neck squamous cell carcinoma. Tumor Biol. 2013;34:1847–54.

    Article  CAS  Google Scholar 

  26. Allison SJ, Jiang M, Milner J. Oncogenic viral protein HPV E7 up-regulates the SIRT1 longevity protein in human cervical cancer cells. Aging. 2009;1:316–27.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Michishita E, Park JY, Burneskis JM, Barrett JC, Horikawa I. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell. 2005;16:4623–35.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Kiran S, Anwar T, Kiran M, Ramakrishna G. Sirtuin 7 in cell proliferation, stress and disease: rise of the seventh Sirtuin! Cell Signal. 2015;3:673–82.

    Article  Google Scholar 

  29. Villalba JM, Alcaín FJ. Sirtuin activators and inhibitors. Biofactors. 2012;38:349–59.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Feng W, Xiao J, Zhang Z, Rosen DG, Brown RE, Liu J, et al. Senescence and apoptosis in carcinogenesis of cervical squamous carcinoma. Mod Pathol. 2007;20:961–6.

    Article  CAS  PubMed  Google Scholar 

  31. Lomnytska MI, Becker S, Bodin I, Olsson A, Hellman K, Hellstrȍm A-C, et al. Differential expression of ANXA6, HSP27, PRDX2, NCF2, and TPM4 during uterine cervix carcinogenesis: diagnostic and prognostic value. Br J Can. 2011;104:110–9.

    Article  CAS  Google Scholar 

  32. Ram BM, Ramakrishna G. Endoplasmic reticulum vacuolation and unfolded protein response leading to paraptosis like cell death in cyclosporine A treated cancer cervix cells is mediated by cyclophilin B inhibition. Biochim Biophys Acta. 2014;1843(11):2497–512.

    Article  CAS  PubMed  Google Scholar 

  33. Kiran S, Chatterjee N, Singh S, Kaul SC, Wadhwa R, Ramakrishna G. Intracellular distribution of human SIRT7 and mapping of the nuclear/nucleolar localization signal. FEBS J. 2013;280:3451–66.

    Article  CAS  PubMed  Google Scholar 

  34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–8.

    Article  CAS  PubMed  Google Scholar 

  35. Maxwell MM, Tomkinson EM, Nobles J, Wizeman JW, Amore AM, Quinti L, et al. The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS. Hum Mol Genet. 2011;15:3986–96.

    Article  Google Scholar 

  36. Chhabra S, Bhavani M, Mahajan N, Bawaskar R. Cervical cancer in Indian rural women: trends over two decades. J Obstet Gynaecol. 2010;30:725–8.

    Article  CAS  PubMed  Google Scholar 

  37. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine. 2006;24(S3):1–10.

    Article  Google Scholar 

  38. Ota H, Tokunaga E, Chang K, Hikasa M, Iijima K, Eto M, et al. Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells. Oncogene. 2006;25:176–85.

    CAS  PubMed  Google Scholar 

  39. Kabra N, Li Z, Chen L, Li B, Zhang X, Wang C, et al. SirT1 is an inhibitor of proliferation and tumor formation in colon cancer. J Biol Chem. 2009;284:18210–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Byles V, Chmilewski LK, Wang J, Zhu L, Forman LW, Faller DV, et al. Aberrant cytoplasm localization and protein stability of SIRT1 is regulated by PI3K/IGF-1R signalling in human cancer cells. Int J Biol Sci. 2010;6:599–612.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Kuo SJ, Lin HY, Chien SY, Chen DR. SIRT1 suppresses breast cancer growth cancer growth through downregulation of Bcl-2 protein. Oncol Rep. 2013;30:125–30.

    CAS  PubMed  Google Scholar 

  42. Jang KY, Hwang SH, Kwon KS, Kang MJ, Lee DG, Kim HS, et al. SIRT1 expression is associated with poor prognosis of diffuse large B-cell lymphoma. Am J Surg Pathol. 2008;32:1523–31.

    Article  PubMed  Google Scholar 

  43. Hou H, Chen W, Zhao L, Zuo Q, Zhang G, Zhang X, et al. Cortactin is associated with tumor progression and poor prognosis in prostate cancer and SIRT2 other than HADC6 may work as facilitator in situ. J Clin Pathol. 2012;65:1088–96.

    Article  PubMed  Google Scholar 

  44. Chen J, Chan AW, To KF, Chen W, Zhang Z, Ren J, et al. SIRT2 overexpression in hepatocellular carcinoma mediates epithelial to mesenchymal transition by protein kinase B/glycogen synthase kinase-3β/β-catenin signaling. Hepatology. 2013;57:2287–98.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Dr. Lucy M. Anderson for the valuable suggestions, critical reading, and editing. SS is supported by a fellowship from the Department of Biotechnology. Laboratory of GR is supported by the funding from the Department of Biotechnology, New Delhi, India. We thank Mr. Bala for the help in flow cytometry. We thank Dr Nirupama Chatterjee for the help with statistical analysis. The critical comments and suggestions from the anonymous reviewers have helped immensely to improve the manuscript.

Conflicts of interest

None

Author contribution

SS performed all the experiments with the help from ST and SK. PAR helped in immunohistochemistry; BS and SS helped in immunoblotting. VVR performed the statistical analysis. The pathological evaluations were by UK. GR designed the study and wrote the manuscript with inputs from SS.

Author information

Author notes

  1. Gayatri Ramakrishna

    Present address: Laboratory of Cancer Cell Biology, Department of Research, Institute of Liver and Biliary Sciences (ILBS), D1 Block, Vasant Kunj, Delhi, 110070, India

Authors and Affiliations

  1. Centre for DNA Fingerprinting and Diagnostics, Hyderabad, India

    Sapna Singh & Shashi Kiran

  2. National Institute of Nutrition, Hyderabad, India

    Sapna Singh, P. Uday Kumar & Vishnu Vardhan Rao

  3. BioGenex Lab Inc, Hyderabad, India

    Suresh Thakur & A. R. Poongothai

  4. Laboratory of Cancer Cell Biology, Department of Research, Institute of Liver and Biliary Sciences (ILBS), D1 Block, Vasant Kunj, Delhi, 110070, India

    Bijoya Sen & Shreya Sharma

Authors
  1. Sapna Singh
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. P. Uday Kumar
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. Suresh Thakur
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. Shashi Kiran
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. Bijoya Sen
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. Shreya Sharma
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. Vishnu Vardhan Rao
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. A. R. Poongothai
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. Gayatri Ramakrishna
    View author publications

    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence to Gayatri Ramakrishna.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Data 1

(SD1) Details of the antibodies used for immunohistochemistry and the standardized conditions. (DOCX 14 kb)

Supplementary Data 2

(SD2) SIRT1 immunohistochemistry in cervical epithelium. A. Immunohistchemistry for SIRT1 expression in normal, SIL and SCC cases. Note the intense cytoplasmic and nuclear expression of SIRT1 in SIL cases compared to normal. B. Pie chart indicating heterogeneous expression pattern of SIRT1 in squamous cell carcinoma (SCC) as noted in immunohistochemistry. (GIF 253 kb)

High Resolution Image (TIFF 20154 kb)

Supplementary Data 3

(SD3) 1A Chi-Square Values of immunohistochemical expression profile of SIRT1, SIRT2 and SIRT7 in Normal, SIL and SCC cases as shown in Table 2 of the main text. 1B Chi-Square Values of Co-expression/association of sirtuin isoforms and p27 as shown in Table 3. of the main text. 1C: Chi-Square Values of Co-expression of sirtuin isoforms and p27 in various stages of cancer. (DOC 53 kb)

Supplementary Data 4

(SD4) Expression analysis of sirtuin proteins (SIRT1, SIRT2 and SIRT7) by immunoblot as seen in different replicate experiments. (GIF 6 kb)

High Resolution Image (TIFF 1502 kb)

Supplementary Data 5

(SD5) Effect of Sirtinol on growth of SiHa cells. A. Bar diagram indicating viability of SiHa cells treated with either solvent alone or with different doses of Sirtinol. Superscripts a and b indicate significant difference with control and treatment with 50 μM dose of Sirtinol respectively (P < 0.05). B. Phase contrast images of cells treated with 100 μM of Sirtinol (20× magnification). C and D. Cell cycle profile and distribution of SiHa cells in various cell cycle phases following treatment with Sirtinol (100 μM) and evaluated by flow cytometry. (GIF 44 kb)

High Resolution Image (TIFF 17956 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, S., Kumar, P.U., Thakur, S. et al. Expression/localization patterns of sirtuins (SIRT1, SIRT2, and SIRT7) during progression of cervical cancer and effects of sirtuin inhibitors on growth of cervical cancer cells. Tumor Biol. 36, 6159–6171 (2015). https://doi.org/10.1007/s13277-015-3300-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13277-015-3300-y

Keywords